Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis
Gonzalo Salazar de Pablo, Filippo Besana, Vincenzo Arienti, et al.
EClinicalMedicine (2021) Vol. 36, pp. 100909-100909
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment
Marco Solmi, Livia Soardo, Simi Kaur, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2291-2300
Open Access | Times Cited: 48
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
Michael P. Harms, Kang Ik K. Cho, Alan Anticevic, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 3
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program
Tashrif Billah, Kang Ik K. Cho, Owen Borders, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk
Meghan A. Collins, Jie Lisa Ji, Yoonho Chung, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1182-1189
Open Access | Times Cited: 46
Accelerating Medicines Partnership® Schizophrenia (AMP®SCZ): developing tools to enable early intervention in the psychosis high risk state
Linda S. Brady, Carlos A. Larrauri
World Psychiatry (2023) Vol. 22, Iss. 1, pp. 42-43
Open Access | Times Cited: 41
Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis
Gonzalo Salazar de Pablo, Ana Catalán, Julio Vaquerizo Serrano, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 1, pp. 282-294
Open Access | Times Cited: 25
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Scott W. Woods, Sophie Parker, Melissa Kerr, et al.
Early Intervention in Psychiatry (2023) Vol. 18, Iss. 4, pp. 255-272
Open Access | Times Cited: 23
Association between Adverse Childhood Experiences and long-term outcomes in people at Clinical High-Risk for Psychosis
Stefania Tognin, Ana Catalán, Clàudia Aymerich, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Prevalence of Individuals at Clinical High-Risk of Psychosis in the General Population and Clinical Samples: Systematic Review and Meta-Analysis
Gonzalo Salazar de Pablo, Scott W. Woods, Georgia Drymonitou, et al.
Brain Sciences (2021) Vol. 11, Iss. 11, pp. 1544-1544
Open Access | Times Cited: 53
Racism and psychosis: an umbrella review and qualitative analysis of the mental health consequences of racism
Felicia Boma Lazaridou, Saskia Schubert, Tobias Ringeisen, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 5, pp. 1009-1022
Open Access | Times Cited: 25
Treating negative symptoms of schizophrenia: current approaches and future perspectives
Oliver Howes, Paolo Fusar‐Poli, Martin Osugo
The British Journal of Psychiatry (2023) Vol. 223, Iss. 1, pp. 332-335
Open Access | Times Cited: 13
Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis
Ana Catalán, Joaquim Radúa, Robert A. McCutcheon, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Treatment Options for Psychotic Depression in Adolescents: A Comprehensive Review
Violeta Pérez-Rodríguez, Clàudia Aymerich, Ana Catalán, et al.
Psychology Research and Behavior Management (2025) Vol. Volume 18, pp. 197-208
Open Access
Interrelationships of Changes in Outcome Domains in Patients With Schizophrenia Spectrum Disorders: A Meta‐Analysis
Lars de Winter, Auke Jelsma, Jentien M. Vermeulen, et al.
Acta Psychiatrica Scandinavica (2025)
Open Access
PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample
Stefania Tognin, Sandra Vieira, Dominic Oliver, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
IQ and socio-occupational functioning in relation to obsessive-compulsive symptoms severity in a clinical sample of adolescents
Riccardo Stefanelli, Orlandi Marika, Diandra C. Bouter, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence
Alexis E. Cullen, Javier Labad, Dominic Oliver, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 350-377
Open Access | Times Cited: 10
Short- and long-term changes in symptom dimensions among patients with schizophrenia spectrum disorders and different durations of illness: A meta-analysis
Lars de Winter, Jentien M. Vermeulen, Chrisje Couwenbergh, et al.
Journal of Psychiatric Research (2023) Vol. 164, pp. 416-439
Open Access | Times Cited: 10
Review: Efficacy of preventative interventions for children and adolescents at clinical high risk of psychosis – a systematic review and meta‐analysis of intervention studies
Grace Frearson, J. Olivares, Ana Catalán, et al.
Child and Adolescent Mental Health (2024)
Open Access | Times Cited: 3
Prevalence and incidence of psychotic disorders in 22q11.2 deletion syndrome: a meta-analysis
Umberto Provenzani, Stefano Damiani, Ilaria Bersano, et al.
International Review of Psychiatry (2022) Vol. 34, Iss. 7-8, pp. 676-688
Open Access | Times Cited: 15
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Scott W. Woods, Sophie Parker, Melissa Kerr, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Moving from risk to resilience in psychosis research
Katharine N. Thakkar, Amanda McCleery, Kyle S. Minor, et al.
Nature Reviews Psychology (2023) Vol. 2, Iss. 9, pp. 537-555
Closed Access | Times Cited: 8
A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB study
Inti Qurashi, Imran B. Chaudhry, Ameer B. Khoso, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 609-616
Open Access | Times Cited: 7
A network analysis of anxiety, depressive, and psychotic symptoms and functioning in children and adolescents at clinical high risk for psychosis
Gabriele Lo Buglio, Maria Pontillo, Erika Cerasti, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 12
Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review
Borja Pedruzo, Clàudia Aymerich, Malein Pacho, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 10, pp. 3377-3387
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top